Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ITC filings 12-23 & 12-24-13 . . .

"Parties found to infringe a valid U.S. patent—in the ITC or otherwise—are always at a disadvantage at the bargaining table, and rightly so. Respondents cite no authority to suggest that the monopoly granted by the Patent Clause of the U.S. Constitution should be supplanted so that they can negotiate a better license rate.

To the contrary, Respondents’ continued unlawful importation of infringing goods would continue to harm Complainants’ intellectual property rights and, by extension, the public interest. "

Share
New Message
Please login to post a reply